

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Golgi transport vesicle coating (GO:0048200) | 6.90073324 |
| 2 | COPI coating of Golgi vesicle (GO:0048205) | 6.90073324 |
| 3 | protein maturation by protein folding (GO:0022417) | 4.80046507 |
| 4 | endocrine pancreas development (GO:0031018) | 4.77065224 |
| 5 | peptide hormone processing (GO:0016486) | 4.72470264 |
| 6 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 4.56213072 |
| 7 | presynaptic membrane assembly (GO:0097105) | 4.49237763 |
| 8 | insulin secretion (GO:0030073) | 4.44907538 |
| 9 | retrograde vesicle-mediated transport, Golgi to ER (GO:0006890) | 4.43536009 |
| 10 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 4.29872227 |
| 11 | regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902235 | 4.24243522 |
| 12 | presynaptic membrane organization (GO:0097090) | 4.16743448 |
| 13 | detection of calcium ion (GO:0005513) | 4.09924585 |
| 14 | positive regulation of insulin secretion (GO:0032024) | 3.93056207 |
| 15 | postsynaptic membrane organization (GO:0001941) | 3.92887303 |
| 16 | regulation of type B pancreatic cell apoptotic process (GO:2000674) | 3.86705743 |
| 17 | glandular epithelial cell differentiation (GO:0002067) | 3.83410488 |
| 18 | COPII vesicle coating (GO:0048208) | 3.83366018 |
| 19 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 3.76839763 |
| 20 | regulation of insulin secretion (GO:0050796) | 3.76352199 |
| 21 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 3.72798996 |
| 22 | regulation of synaptic vesicle exocytosis (GO:2000300) | 3.71724454 |
| 23 | protein retention in ER lumen (GO:0006621) | 3.71246221 |
| 24 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 3.69952757 |
| 25 | dendritic spine morphogenesis (GO:0060997) | 3.67990084 |
| 26 | synaptic vesicle maturation (GO:0016188) | 3.67556715 |
| 27 | type B pancreatic cell development (GO:0003323) | 3.63938384 |
| 28 | ER overload response (GO:0006983) | 3.61807906 |
| 29 | gamma-aminobutyric acid transport (GO:0015812) | 3.53402880 |
| 30 | glycerophospholipid catabolic process (GO:0046475) | 3.50126510 |
| 31 | nucleobase catabolic process (GO:0046113) | 3.46373945 |
| 32 | synaptic vesicle exocytosis (GO:0016079) | 3.45750090 |
| 33 | activation of signaling protein activity involved in unfolded protein response (GO:0006987) | 3.44358790 |
| 34 | vesicle coating (GO:0006901) | 3.43379352 |
| 35 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 3.43104784 |
| 36 | regulation of peptide hormone secretion (GO:0090276) | 3.42198163 |
| 37 | synaptic transmission, glutamatergic (GO:0035249) | 3.38657213 |
| 38 | regulation of peptide secretion (GO:0002791) | 3.38482840 |
| 39 | nitric oxide mediated signal transduction (GO:0007263) | 3.36318285 |
| 40 | glandular epithelial cell development (GO:0002068) | 3.36016151 |
| 41 | glutamate receptor signaling pathway (GO:0007215) | 3.35127379 |
| 42 | peptide hormone secretion (GO:0030072) | 3.32114273 |
| 43 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 3.31750055 |
| 44 | negative regulation of cytosolic calcium ion concentration (GO:0051481) | 3.30206918 |
| 45 | regulation of respiratory gaseous exchange by neurological system process (GO:0002087) | 3.29643376 |
| 46 | pyrimidine nucleobase catabolic process (GO:0006208) | 3.27599211 |
| 47 | auditory behavior (GO:0031223) | 3.25821800 |
| 48 | peptide secretion (GO:0002790) | 3.24628409 |
| 49 | regulation of calcium ion-dependent exocytosis (GO:0017158) | 3.23420316 |
| 50 | regulation of synaptic vesicle transport (GO:1902803) | 3.22110881 |
| 51 | positive regulation of nuclease activity (GO:0032075) | 3.21826661 |
| 52 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 3.21202961 |
| 53 | positive regulation of peptide hormone secretion (GO:0090277) | 3.21144212 |
| 54 | cerebellar Purkinje cell layer development (GO:0021680) | 3.20487199 |
| 55 | positive regulation of peptide secretion (GO:0002793) | 3.18539997 |
| 56 | neuron-neuron synaptic transmission (GO:0007270) | 3.18404322 |
| 57 | chemosensory behavior (GO:0007635) | 3.17514141 |
| 58 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 3.16947058 |
| 59 | regulation of beta-amyloid formation (GO:1902003) | 3.16800628 |
| 60 | locomotory exploration behavior (GO:0035641) | 3.16072648 |
| 61 | startle response (GO:0001964) | 3.15354399 |
| 62 | exocrine pancreas development (GO:0031017) | 3.14304026 |
| 63 | cellular response to glucagon stimulus (GO:0071377) | 3.13865552 |
| 64 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 3.13606417 |
| 65 | vocalization behavior (GO:0071625) | 3.13418626 |
| 66 | intra-Golgi vesicle-mediated transport (GO:0006891) | 3.13118986 |
| 67 | membrane repolarization during cardiac muscle cell action potential (GO:0086013) | 3.12728676 |
| 68 | behavioral response to nicotine (GO:0035095) | 3.10330875 |
| 69 | negative regulation of catecholamine secretion (GO:0033604) | 3.08788523 |
| 70 | regulation of amyloid precursor protein catabolic process (GO:1902991) | 3.08715912 |
| 71 | neuronal action potential propagation (GO:0019227) | 3.08480085 |
| 72 | positive regulation of synaptic transmission, GABAergic (GO:0032230) | 3.08316796 |
| 73 | signal peptide processing (GO:0006465) | 3.08095875 |
| 74 | regulation of synapse structural plasticity (GO:0051823) | 3.07143300 |
| 75 | negative regulation of norepinephrine secretion (GO:0010700) | 3.05442800 |
| 76 | neurotransmitter-gated ion channel clustering (GO:0072578) | 3.04899197 |
| 77 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 3.03560377 |
| 78 | positive regulation of neurotransmitter transport (GO:0051590) | 3.03394900 |
| 79 | neurotransmitter transport (GO:0006836) | 3.03038912 |
| 80 | regulation of hormone secretion (GO:0046883) | 3.01520809 |
| 81 | regulation of hexokinase activity (GO:1903299) | 3.00754561 |
| 82 | regulation of glucokinase activity (GO:0033131) | 3.00754561 |
| 83 | cellular ketone body metabolic process (GO:0046950) | 3.00475753 |
| 84 | protein localization to synapse (GO:0035418) | 2.99695211 |
| 85 | regulation of glucocorticoid secretion (GO:2000849) | 2.99248932 |
| 86 | innervation (GO:0060384) | 2.98924860 |
| 87 | neuromuscular process controlling posture (GO:0050884) | 2.98870960 |
| 88 | mechanosensory behavior (GO:0007638) | 2.97335012 |
| 89 | glutamate secretion (GO:0014047) | 2.96404830 |
| 90 | activation of protein kinase A activity (GO:0034199) | 2.96206427 |
| 91 | sequestering of metal ion (GO:0051238) | 2.95850914 |
| 92 | inositol phosphate catabolic process (GO:0071545) | 2.94824856 |
| 93 | protein targeting to Golgi (GO:0000042) | 2.94154601 |
| 94 | axonal fasciculation (GO:0007413) | 2.91334923 |
| 95 | synapse assembly (GO:0007416) | 2.90621030 |
| 96 | astrocyte differentiation (GO:0048708) | 2.89608929 |
| 97 | regulation of neurotransmitter levels (GO:0001505) | 2.88595875 |
| 98 | regulation of nuclease activity (GO:0032069) | 2.88179764 |
| 99 | positive regulation of exocytosis (GO:0045921) | 2.87761256 |
| 100 | righting reflex (GO:0060013) | 2.86975234 |
| 101 | cell communication by electrical coupling (GO:0010644) | 2.85666849 |
| 102 | regulation of neurotransmitter uptake (GO:0051580) | 2.85260709 |
| 103 | potassium ion homeostasis (GO:0055075) | 2.84326682 |
| 104 | regulation of respiratory system process (GO:0044065) | 2.83824104 |
| 105 | protein localization to Golgi apparatus (GO:0034067) | 2.83187922 |
| 106 | regulation of vesicle fusion (GO:0031338) | 2.82096591 |
| 107 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 2.82094248 |
| 108 | exploration behavior (GO:0035640) | 2.81480869 |
| 109 | ER-associated ubiquitin-dependent protein catabolic process (GO:0030433) | 2.81043440 |
| 110 | toxin metabolic process (GO:0009404) | 2.80592182 |
| 111 | membrane repolarization during action potential (GO:0086011) | 2.78658989 |
| 112 | endoplasmic reticulum unfolded protein response (GO:0030968) | 2.76853401 |
| 113 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 2.76187239 |
| 114 | response to dietary excess (GO:0002021) | 2.74732582 |
| 115 | inner ear receptor cell development (GO:0060119) | 2.74643741 |
| 116 | potassium ion import (GO:0010107) | 2.74165581 |
| 117 | regulation of insulin secretion involved in cellular response to glucose stimulus (GO:0061178) | 2.73987894 |
| 118 | membrane repolarization (GO:0086009) | 2.73928188 |
| 119 | cellular response to unfolded protein (GO:0034620) | 2.73918184 |
| 120 | regulation of peptide transport (GO:0090087) | 2.73675861 |
| 121 | regulation of postsynaptic membrane potential (GO:0060078) | 2.73212668 |
| 122 | cellular potassium ion homeostasis (GO:0030007) | 2.72999333 |
| 123 | regulation of neurotransmitter transport (GO:0051588) | 2.71525042 |
| 124 | neurotransmitter secretion (GO:0007269) | 2.70498016 |
| 125 | positive regulation of vesicle fusion (GO:0031340) | 2.69379022 |
| 126 | alanine transport (GO:0032328) | 2.69083227 |
| 127 | regulation of neuronal synaptic plasticity (GO:0048168) | 2.67385158 |
| 128 | cellular response to topologically incorrect protein (GO:0035967) | 2.67116610 |
| 129 | ER-nucleus signaling pathway (GO:0006984) | 2.66253969 |
| 130 | proline transport (GO:0015824) | 2.64880694 |
| 131 | regulation of norepinephrine secretion (GO:0014061) | 2.64374884 |
| 132 | neuron recognition (GO:0008038) | 2.63818949 |
| 133 | ketone body metabolic process (GO:1902224) | 2.62954988 |
| 134 | regulation of exocytosis (GO:0017157) | 2.61573285 |
| 135 | signal release (GO:0023061) | 2.61457070 |
| 136 | establishment of protein localization to Golgi (GO:0072600) | 2.61171895 |
| 137 | transmission of nerve impulse (GO:0019226) | 2.60799173 |
| 138 | membrane hyperpolarization (GO:0060081) | 2.60614269 |
| 139 | response to auditory stimulus (GO:0010996) | 2.60451613 |
| 140 | positive regulation of membrane potential (GO:0045838) | 2.60276578 |
| 141 | neurological system process involved in regulation of systemic arterial blood pressure (GO:0001976) | 2.60247747 |
| 142 | macroautophagy (GO:0016236) | 2.59023200 |
| 143 | water-soluble vitamin biosynthetic process (GO:0042364) | 2.58724585 |
| 144 | protein localization to cilium (GO:0061512) | 2.57688785 |
| 145 | positive regulation of hormone secretion (GO:0046887) | 2.56646268 |
| 146 | suckling behavior (GO:0001967) | 2.56100721 |
| 147 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 2.55918308 |
| 148 | negative regulation of glycoprotein biosynthetic process (GO:0010561) | 2.55584923 |
| 149 | positive regulation of neurotransmitter secretion (GO:0001956) | 2.55549055 |
| 150 | regulation of neurotransmitter secretion (GO:0046928) | 2.55538779 |
| 151 | peptide transport (GO:0015833) | 2.55455991 |
| 152 | G-protein coupled glutamate receptor signaling pathway (GO:0007216) | 2.55445050 |
| 153 | positive regulation of potassium ion transport (GO:0043268) | 2.55438928 |
| 154 | hormone secretion (GO:0046879) | 2.55356519 |
| 155 | glycosphingolipid biosynthetic process (GO:0006688) | 2.55323223 |
| 156 | serotonin metabolic process (GO:0042428) | 2.53712326 |
| 157 | negative regulation of insulin secretion (GO:0046676) | 2.52089419 |
| 158 | vesicle transport along microtubule (GO:0047496) | 2.51820713 |
| 159 | regulation of synaptic transmission, glutamatergic (GO:0051966) | 2.51224882 |
| 160 | neuron cell-cell adhesion (GO:0007158) | 2.50880099 |
| 161 | calcium ion-dependent exocytosis (GO:0017156) | 2.50668458 |
| 162 | prepulse inhibition (GO:0060134) | 2.50566961 |
| 163 | negative regulation of calcium ion-dependent exocytosis (GO:0045955) | 2.50060776 |
| 164 | positive regulation of insulin secretion involved in cellular response to glucose stimulus (GO:00357 | 2.49660554 |
| 165 | C4-dicarboxylate transport (GO:0015740) | 2.49656160 |
| 166 | regulation of glutamate receptor signaling pathway (GO:1900449) | 2.49528902 |
| 167 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 2.49486358 |
| 168 | columnar/cuboidal epithelial cell development (GO:0002066) | 2.48368029 |
| 169 | cAMP-mediated signaling (GO:0019933) | 2.48249822 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 4.30801717 |
| 2 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 4.18722602 |
| 3 | GBX2_23144817_ChIP-Seq_PC3_Human | 2.89359552 |
| 4 | * REST_21632747_ChIP-Seq_MESCs_Mouse | 2.81051878 |
| 5 | * SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.49001391 |
| 6 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.36331891 |
| 7 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.33935291 |
| 8 | * REST_18959480_ChIP-ChIP_MESCs_Mouse | 2.23558055 |
| 9 | * SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.16450069 |
| 10 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.11644880 |
| 11 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.11070146 |
| 12 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.03872211 |
| 13 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.00813424 |
| 14 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.98129283 |
| 15 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.94750067 |
| 16 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.94672104 |
| 17 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.94611199 |
| 18 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.94209856 |
| 19 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.93873379 |
| 20 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.89967515 |
| 21 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.89315686 |
| 22 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.87440888 |
| 23 | FUS_26573619_Chip-Seq_HEK293_Human | 1.83695076 |
| 24 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.82627466 |
| 25 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.79954239 |
| 26 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.79954239 |
| 27 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.77824043 |
| 28 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.77723322 |
| 29 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.73318801 |
| 30 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.71653756 |
| 31 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.71625517 |
| 32 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.68597720 |
| 33 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.68507756 |
| 34 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.62120097 |
| 35 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 1.57781643 |
| 36 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.57545457 |
| 37 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.52969169 |
| 38 | STAT3_23295773_ChIP-Seq_U87_Human | 1.51133836 |
| 39 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.47956243 |
| 40 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.47806992 |
| 41 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.46710673 |
| 42 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.44771861 |
| 43 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.38034312 |
| 44 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.35302958 |
| 45 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.34838263 |
| 46 | * OLIG2_26023283_ChIP-Seq_AINV15_Mouse | 1.34103378 |
| 47 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.33450368 |
| 48 | EWS_26573619_Chip-Seq_HEK293_Human | 1.32336825 |
| 49 | GATA1_22025678_ChIP-Seq_K562_Human | 1.30447384 |
| 50 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.29789701 |
| 51 | VDR_22108803_ChIP-Seq_LS180_Human | 1.27930390 |
| 52 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.27104408 |
| 53 | RCOR1_19997604_ChIP-ChIP_NEURONS_Mouse | 1.26177484 |
| 54 | * POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.25919599 |
| 55 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.25793418 |
| 56 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.24509703 |
| 57 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.23844436 |
| 58 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.23844436 |
| 59 | * ER_23166858_ChIP-Seq_MCF-7_Human | 1.23611356 |
| 60 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.23090479 |
| 61 | * RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 1.22608077 |
| 62 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.22319923 |
| 63 | AR_19668381_ChIP-Seq_PC3_Human | 1.21871075 |
| 64 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.21140741 |
| 65 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.21123420 |
| 66 | P300_19829295_ChIP-Seq_ESCs_Human | 1.21012112 |
| 67 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.20606806 |
| 68 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.19580244 |
| 69 | * YAP1_20516196_ChIP-Seq_MESCs_Mouse | 1.18285219 |
| 70 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.17801473 |
| 71 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.17801473 |
| 72 | * BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.17548622 |
| 73 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.16377783 |
| 74 | SMAD3_21741376_ChIP-Seq_ESCs_Human | 1.16244678 |
| 75 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.16163647 |
| 76 | P53_22387025_ChIP-Seq_ESCs_Mouse | 1.15867782 |
| 77 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.14489568 |
| 78 | TP53_22573176_ChIP-Seq_HFKS_Human | 1.13283043 |
| 79 | AR_25329375_ChIP-Seq_VCAP_Human | 1.12952906 |
| 80 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.12153965 |
| 81 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 1.12124959 |
| 82 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 1.12042030 |
| 83 | * TCF4_23295773_ChIP-Seq_U87_Human | 1.11773122 |
| 84 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.09441342 |
| 85 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.09314968 |
| 86 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.09309727 |
| 87 | LMO2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.08461595 |
| 88 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.07843355 |
| 89 | CMYC_18555785_Chip-Seq_ESCs_Mouse | 1.07234562 |
| 90 | TCF4_22108803_ChIP-Seq_LS180_Human | 1.06616855 |
| 91 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 1.06503083 |
| 92 | CRX_20693478_ChIP-Seq_ADULT_RETINA_Mouse | 1.05936778 |
| 93 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.04838729 |
| 94 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 1.04617929 |
| 95 | * TAL1_26923725_Chip-Seq_HPCs_Mouse | 1.04401156 |
| 96 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.04205676 |
| 97 | EBF1_22473956_ChIP-Seq_LYMPHODE_Mouse | 1.03709508 |
| 98 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.03506109 |
| 99 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.03432942 |
| 100 | * REST_19997604_ChIP-ChIP_NEURONS_Mouse | 1.03334791 |
| 101 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.02686724 |
| 102 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 1.01819463 |
| 103 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 1.01797830 |
| 104 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.01158160 |
| 105 | * RUNX2_22187159_ChIP-Seq_PCA_Human | 1.00760891 |
| 106 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.00307813 |
| 107 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.97189543 |
| 108 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 0.96578396 |
| 109 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 0.95240604 |
| 110 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.94118847 |
| 111 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 0.93614837 |
| 112 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.91570138 |
| 113 | * SIN3B_21632747_ChIP-Seq_MESCs_Mouse | 0.91063666 |
| 114 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 0.90775867 |
| 115 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 0.89353013 |
| 116 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.88388332 |
| 117 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 0.87470564 |
| 118 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 0.87353522 |
| 119 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 0.87067373 |
| 120 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.87019387 |
| 121 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 0.86935508 |
| 122 | * TET1_21490601_ChIP-Seq_MESCs_Mouse | 0.85757010 |
| 123 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.85332324 |
| 124 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 0.84956481 |
| 125 | AR_21572438_ChIP-Seq_LNCaP_Human | 0.84887572 |
| 126 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.84294769 |
| 127 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.84279946 |
| 128 | RNF2_27304074_Chip-Seq_NSC_Mouse | 0.83250710 |
| 129 | DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 0.82450226 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002909_abnormal_adrenal_gland | 4.07858265 |
| 2 | MP0009780_abnormal_chondrocyte_physiolo | 3.77805829 |
| 3 | MP0003283_abnormal_digestive_organ | 3.50818637 |
| 4 | MP0000013_abnormal_adipose_tissue | 3.41654532 |
| 5 | MP0004043_abnormal_pH_regulation | 3.27728001 |
| 6 | MP0004270_analgesia | 3.21386304 |
| 7 | MP0002877_abnormal_melanocyte_morpholog | 3.20549078 |
| 8 | MP0003183_abnormal_peptide_metabolism | 2.99209126 |
| 9 | MP0002693_abnormal_pancreas_physiology | 2.91272282 |
| 10 | MP0005379_endocrine/exocrine_gland_phen | 2.83703045 |
| 11 | MP0010386_abnormal_urinary_bladder | 2.80971801 |
| 12 | MP0004859_abnormal_synaptic_plasticity | 2.70375430 |
| 13 | MP0001944_abnormal_pancreas_morphology | 2.66674907 |
| 14 | MP0005646_abnormal_pituitary_gland | 2.47645518 |
| 15 | MP0008877_abnormal_DNA_methylation | 2.42485317 |
| 16 | MP0005645_abnormal_hypothalamus_physiol | 2.33534593 |
| 17 | MP0001986_abnormal_taste_sensitivity | 2.30389246 |
| 18 | MP0002734_abnormal_mechanical_nocicepti | 2.26021638 |
| 19 | MP0003635_abnormal_synaptic_transmissio | 2.22620700 |
| 20 | MP0002837_dystrophic_cardiac_calcinosis | 2.18715684 |
| 21 | MP0002638_abnormal_pupillary_reflex | 2.18286157 |
| 22 | MP0003195_calcinosis | 2.15796608 |
| 23 | MP0006072_abnormal_retinal_apoptosis | 2.14300998 |
| 24 | MP0000678_abnormal_parathyroid_gland | 2.12999509 |
| 25 | MP0002733_abnormal_thermal_nociception | 2.02880725 |
| 26 | MP0002822_catalepsy | 2.02835191 |
| 27 | MP0003122_maternal_imprinting | 1.86691792 |
| 28 | MP0003121_genomic_imprinting | 1.78095632 |
| 29 | MP0001968_abnormal_touch/_nociception | 1.77266760 |
| 30 | MP0002078_abnormal_glucose_homeostasis | 1.71658661 |
| 31 | MP0002063_abnormal_learning/memory/cond | 1.71577413 |
| 32 | MP0001970_abnormal_pain_threshold | 1.68174142 |
| 33 | MP0002735_abnormal_chemical_nociception | 1.67279972 |
| 34 | MP0002572_abnormal_emotion/affect_behav | 1.65944084 |
| 35 | MP0002272_abnormal_nervous_system | 1.62193558 |
| 36 | MP0001188_hyperpigmentation | 1.58509662 |
| 37 | MP0002064_seizures | 1.57836776 |
| 38 | MP0009745_abnormal_behavioral_response | 1.56535322 |
| 39 | MP0004858_abnormal_nervous_system | 1.56527776 |
| 40 | MP0001502_abnormal_circadian_rhythm | 1.56236065 |
| 41 | MP0001529_abnormal_vocalization | 1.56190899 |
| 42 | MP0005220_abnormal_exocrine_pancreas | 1.53415621 |
| 43 | MP0000003_abnormal_adipose_tissue | 1.52595889 |
| 44 | MP0003123_paternal_imprinting | 1.52144791 |
| 45 | MP0008961_abnormal_basal_metabolism | 1.40534588 |
| 46 | MP0003172_abnormal_lysosome_physiology | 1.40305578 |
| 47 | MP0001905_abnormal_dopamine_level | 1.40008414 |
| 48 | MP0004142_abnormal_muscle_tone | 1.38070479 |
| 49 | MP0002736_abnormal_nociception_after | 1.36834376 |
| 50 | MP0001984_abnormal_olfaction | 1.35168122 |
| 51 | MP0003880_abnormal_central_pattern | 1.34782232 |
| 52 | MP0002102_abnormal_ear_morphology | 1.34360475 |
| 53 | MP0000631_abnormal_neuroendocrine_gland | 1.32095198 |
| 54 | MP0002234_abnormal_pharynx_morphology | 1.31821631 |
| 55 | MP0006276_abnormal_autonomic_nervous | 1.30862592 |
| 56 | MP0001486_abnormal_startle_reflex | 1.30823844 |
| 57 | MP0009046_muscle_twitch | 1.30277407 |
| 58 | MP0003329_amyloid_beta_deposits | 1.29835569 |
| 59 | MP0000955_abnormal_spinal_cord | 1.28822828 |
| 60 | MP0002557_abnormal_social/conspecific_i | 1.27659128 |
| 61 | MP0005423_abnormal_somatic_nervous | 1.26044774 |
| 62 | MP0002067_abnormal_sensory_capabilities | 1.25621148 |
| 63 | MP0008569_lethality_at_weaning | 1.24350178 |
| 64 | MP0002184_abnormal_innervation | 1.19911683 |
| 65 | MP0003953_abnormal_hormone_level | 1.17836660 |
| 66 | MP0004885_abnormal_endolymph | 1.16055599 |
| 67 | MP0001765_abnormal_ion_homeostasis | 1.15811031 |
| 68 | MP0005535_abnormal_body_temperature | 1.15769530 |
| 69 | MP0001501_abnormal_sleep_pattern | 1.13058007 |
| 70 | MP0000462_abnormal_digestive_system | 1.11865484 |
| 71 | MP0001299_abnormal_eye_distance/ | 1.10803143 |
| 72 | MP0004133_heterotaxia | 1.10438011 |
| 73 | MP0005253_abnormal_eye_physiology | 1.10225582 |
| 74 | MP0003879_abnormal_hair_cell | 1.04981488 |
| 75 | MP0003634_abnormal_glial_cell | 1.04857187 |
| 76 | MP0002896_abnormal_bone_mineralization | 1.04681131 |
| 77 | MP0003787_abnormal_imprinting | 1.04465166 |
| 78 | MP0004811_abnormal_neuron_physiology | 1.04115629 |
| 79 | MP0003633_abnormal_nervous_system | 1.03906184 |
| 80 | MP0001440_abnormal_grooming_behavior | 1.03672019 |
| 81 | MP0001485_abnormal_pinna_reflex | 1.00733865 |
| 82 | MP0003011_delayed_dark_adaptation | 0.98416550 |
| 83 | MP0002882_abnormal_neuron_morphology | 0.97203254 |
| 84 | MP0002163_abnormal_gland_morphology | 0.96844057 |
| 85 | MP0002876_abnormal_thyroid_physiology | 0.96553507 |
| 86 | MP0005386_behavior/neurological_phenoty | 0.95660897 |
| 87 | MP0004924_abnormal_behavior | 0.95660897 |
| 88 | MP0002229_neurodegeneration | 0.95305967 |
| 89 | MP0001270_distended_abdomen | 0.94349232 |
| 90 | MP0002653_abnormal_ependyma_morphology | 0.90290025 |
| 91 | MP0004145_abnormal_muscle_electrophysio | 0.89485373 |
| 92 | MP0003868_abnormal_feces_composition | 0.89332718 |
| 93 | MP0002069_abnormal_eating/drinking_beha | 0.88258191 |
| 94 | MP0005551_abnormal_eye_electrophysiolog | 0.87295636 |
| 95 | MP0006292_abnormal_olfactory_placode | 0.87229676 |
| 96 | MP0002066_abnormal_motor_capabilities/c | 0.86714432 |
| 97 | MP0000569_abnormal_digit_pigmentation | 0.85495377 |
| 98 | MP0004264_abnormal_extraembryonic_tissu | 0.84167533 |
| 99 | MP0002928_abnormal_bile_duct | 0.83764288 |
| 100 | MP0000778_abnormal_nervous_system | 0.82675185 |
| 101 | MP0004742_abnormal_vestibular_system | 0.82498514 |
| 102 | MP0000639_abnormal_adrenal_gland | 0.81707786 |
| 103 | MP0005084_abnormal_gallbladder_morpholo | 0.80469155 |
| 104 | MP0003690_abnormal_glial_cell | 0.80332150 |
| 105 | MP0002152_abnormal_brain_morphology | 0.80038610 |
| 106 | MP0004147_increased_porphyrin_level | 0.80005376 |
| 107 | MP0000427_abnormal_hair_cycle | 0.75568823 |
| 108 | MP0008872_abnormal_physiological_respon | 0.75495110 |
| 109 | MP0001756_abnormal_urination | 0.74854970 |
| 110 | MP0000613_abnormal_salivary_gland | 0.73793310 |
| 111 | MP0005058_abnormal_lysosome_morphology | 0.73678255 |
| 112 | MP0002752_abnormal_somatic_nervous | 0.72598437 |
| 113 | MP0005257_abnormal_intraocular_pressure | 0.72547902 |
| 114 | MP0005187_abnormal_penis_morphology | 0.72224343 |
| 115 | MP0001963_abnormal_hearing_physiology | 0.72105366 |
| 116 | MP0002751_abnormal_autonomic_nervous | 0.71912060 |
| 117 | MP0001664_abnormal_digestion | 0.71464822 |
| 118 | MP0004085_abnormal_heartbeat | 0.71237828 |
| 119 | MP0003959_abnormal_lean_body | 0.71219721 |
| 120 | MP0003631_nervous_system_phenotype | 0.69692083 |
| 121 | MP0002090_abnormal_vision | 0.69394023 |
| 122 | MP0003632_abnormal_nervous_system | 0.69391704 |
| 123 | MP0003890_abnormal_embryonic-extraembry | 0.69248096 |
| 124 | MP0004215_abnormal_myocardial_fiber | 0.68943142 |
| 125 | MP0005448_abnormal_energy_balance | 0.68556614 |
| 126 | MP0000230_abnormal_systemic_arterial | 0.66432271 |
| 127 | MP0003300_gastrointestinal_ulcer | 0.66264870 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Hyperinsulinemic hypoglycemia (HP:0000825) | 6.50559766 |
| 2 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 6.32172755 |
| 3 | Hypoglycemic seizures (HP:0002173) | 5.88525183 |
| 4 | Symptomatic seizures (HP:0011145) | 5.38138549 |
| 5 | Abnormality of calcium-phosphate metabolism (HP:0100530) | 4.49402243 |
| 6 | Hypoglycemic coma (HP:0001325) | 4.45675854 |
| 7 | Insulin-resistant diabetes mellitus (HP:0000831) | 3.99635183 |
| 8 | Large for gestational age (HP:0001520) | 3.83126635 |
| 9 | Agitation (HP:0000713) | 3.81003992 |
| 10 | Hyperglycemia (HP:0003074) | 3.78313188 |
| 11 | Ketoacidosis (HP:0001993) | 3.66371785 |
| 12 | Abnormality of endocrine pancreas physiology (HP:0012093) | 3.57974331 |
| 13 | Abnormality of the pancreatic islet cells (HP:0006476) | 3.57974331 |
| 14 | Visual hallucinations (HP:0002367) | 3.56174187 |
| 15 | Pancreatic islet-cell hyperplasia (HP:0004510) | 3.45481791 |
| 16 | Decreased circulating renin level (HP:0003351) | 3.44443974 |
| 17 | Pheochromocytoma (HP:0002666) | 3.29546756 |
| 18 | Late onset (HP:0003584) | 3.28061599 |
| 19 | EEG with generalized epileptiform discharges (HP:0011198) | 3.16612580 |
| 20 | Hypsarrhythmia (HP:0002521) | 3.09848717 |
| 21 | Epileptiform EEG discharges (HP:0011182) | 3.07863757 |
| 22 | Polyphagia (HP:0002591) | 3.07023823 |
| 23 | Papilledema (HP:0001085) | 3.06640438 |
| 24 | Dysostosis multiplex (HP:0000943) | 2.97466237 |
| 25 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.93057981 |
| 26 | Mucopolysacchariduria (HP:0008155) | 2.93057981 |
| 27 | Neuroendocrine neoplasm (HP:0100634) | 2.91738640 |
| 28 | Abnormal pancreas size (HP:0012094) | 2.89643654 |
| 29 | Hyperparathyroidism (HP:0000843) | 2.76577420 |
| 30 | Retinal atrophy (HP:0001105) | 2.76428681 |
| 31 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.76221740 |
| 32 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.76221740 |
| 33 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.76221740 |
| 34 | Hypokalemia (HP:0002900) | 2.76140769 |
| 35 | Medial flaring of the eyebrow (HP:0010747) | 2.75795206 |
| 36 | Megalencephaly (HP:0001355) | 2.74551378 |
| 37 | Dysautonomia (HP:0002459) | 2.71133252 |
| 38 | Hyperventilation (HP:0002883) | 2.64778372 |
| 39 | Focal motor seizures (HP:0011153) | 2.62501406 |
| 40 | Hypomagnesemia (HP:0002917) | 2.60315657 |
| 41 | Abnormal eating behavior (HP:0100738) | 2.57240435 |
| 42 | Menstrual irregularities (HP:0000858) | 2.54478275 |
| 43 | Progressive macrocephaly (HP:0004481) | 2.50337078 |
| 44 | Poor suck (HP:0002033) | 2.50047833 |
| 45 | Intestinal atresia (HP:0011100) | 2.45116812 |
| 46 | Abnormality of the labia minora (HP:0012880) | 2.43169720 |
| 47 | Epileptic encephalopathy (HP:0200134) | 2.42844365 |
| 48 | Abnormality of renin-angiotensin system (HP:0000847) | 2.41948911 |
| 49 | Methylmalonic acidemia (HP:0002912) | 2.38386055 |
| 50 | Hypothermia (HP:0002045) | 2.38242552 |
| 51 | Supranuclear gaze palsy (HP:0000605) | 2.37750482 |
| 52 | Gaze-evoked nystagmus (HP:0000640) | 2.35856810 |
| 53 | Intention tremor (HP:0002080) | 2.35629598 |
| 54 | Depression (HP:0000716) | 2.32373296 |
| 55 | Congenital primary aphakia (HP:0007707) | 2.31802700 |
| 56 | Restlessness (HP:0000711) | 2.31309288 |
| 57 | Atonic seizures (HP:0010819) | 2.29522954 |
| 58 | Broad-based gait (HP:0002136) | 2.29101809 |
| 59 | Hypercortisolism (HP:0001578) | 2.28946590 |
| 60 | Anxiety (HP:0000739) | 2.27943915 |
| 61 | Increased circulating renin level (HP:0000848) | 2.26040605 |
| 62 | Drooling (HP:0002307) | 2.24397329 |
| 63 | Congenital malformation of the right heart (HP:0011723) | 2.24394240 |
| 64 | Double outlet right ventricle (HP:0001719) | 2.24394240 |
| 65 | Osteomalacia (HP:0002749) | 2.23588639 |
| 66 | Neurofibrillary tangles (HP:0002185) | 2.22782292 |
| 67 | Failure to thrive in infancy (HP:0001531) | 2.22194886 |
| 68 | Abnormality of potassium homeostasis (HP:0011042) | 2.22164705 |
| 69 | Pancreatic fibrosis (HP:0100732) | 2.20335963 |
| 70 | Abnormal drinking behavior (HP:0030082) | 2.19355253 |
| 71 | Polydipsia (HP:0001959) | 2.19355253 |
| 72 | Nephronophthisis (HP:0000090) | 2.18872291 |
| 73 | Aplasia/Hypoplasia of the fovea (HP:0008060) | 2.18650962 |
| 74 | Hypoplasia of the fovea (HP:0007750) | 2.18650962 |
| 75 | Postural tremor (HP:0002174) | 2.16809297 |
| 76 | Abnormality of the fovea (HP:0000493) | 2.15659769 |
| 77 | Acute necrotizing encephalopathy (HP:0006965) | 2.14757364 |
| 78 | Action tremor (HP:0002345) | 2.14382774 |
| 79 | Generalized tonic-clonic seizures (HP:0002069) | 2.11859905 |
| 80 | Truncal ataxia (HP:0002078) | 2.10772062 |
| 81 | Nephrogenic diabetes insipidus (HP:0009806) | 2.10505180 |
| 82 | Hemiparesis (HP:0001269) | 2.09426733 |
| 83 | Cortical visual impairment (HP:0100704) | 2.09421617 |
| 84 | Absence seizures (HP:0002121) | 2.08229641 |
| 85 | Prominent metopic ridge (HP:0005487) | 2.07853115 |
| 86 | Macroorchidism (HP:0000053) | 2.06963761 |
| 87 | Enlarged penis (HP:0000040) | 2.06232627 |
| 88 | Focal seizures (HP:0007359) | 2.06223265 |
| 89 | Abnormality of vitamin B metabolism (HP:0004340) | 2.03084150 |
| 90 | Progressive neurologic deterioration (HP:0002344) | 2.02991961 |
| 91 | Congenital glaucoma (HP:0001087) | 2.02953620 |
| 92 | Hepatoblastoma (HP:0002884) | 2.01007325 |
| 93 | Excessive salivation (HP:0003781) | 2.00995572 |
| 94 | Myokymia (HP:0002411) | 2.00286887 |
| 95 | Amblyopia (HP:0000646) | 1.99130023 |
| 96 | Hyperkalemia (HP:0002153) | 1.98514534 |
| 97 | True hermaphroditism (HP:0010459) | 1.98085711 |
| 98 | Unilateral renal agenesis (HP:0000122) | 1.97905428 |
| 99 | Pancreatic cysts (HP:0001737) | 1.97821749 |
| 100 | Insulin resistance (HP:0000855) | 1.97207707 |
| 101 | Conjugated hyperbilirubinemia (HP:0002908) | 1.97138794 |
| 102 | Progressive cerebellar ataxia (HP:0002073) | 1.96711315 |
| 103 | Absent speech (HP:0001344) | 1.96286963 |
| 104 | Abnormality of midbrain morphology (HP:0002418) | 1.96074160 |
| 105 | Molar tooth sign on MRI (HP:0002419) | 1.96074160 |
| 106 | Status epilepticus (HP:0002133) | 1.96021232 |
| 107 | Type II lissencephaly (HP:0007260) | 1.95701796 |
| 108 | Abnormality of magnesium homeostasis (HP:0004921) | 1.95007872 |
| 109 | Spastic tetraplegia (HP:0002510) | 1.94683466 |
| 110 | Sleep apnea (HP:0010535) | 1.93884293 |
| 111 | Abnormality of the metopic suture (HP:0005556) | 1.90022371 |
| 112 | Genital tract atresia (HP:0001827) | 1.87908706 |
| 113 | Dialeptic seizures (HP:0011146) | 1.87442624 |
| 114 | Generalized aminoaciduria (HP:0002909) | 1.87406773 |
| 115 | Fetal akinesia sequence (HP:0001989) | 1.86197656 |
| 116 | Generalized myoclonic seizures (HP:0002123) | 1.85629800 |
| 117 | Specific learning disability (HP:0001328) | 1.85116805 |
| 118 | Dysdiadochokinesis (HP:0002075) | 1.84853929 |
| 119 | Retinal dysplasia (HP:0007973) | 1.84702509 |
| 120 | Cerebral inclusion bodies (HP:0100314) | 1.84265574 |
| 121 | Neoplasm of the heart (HP:0100544) | 1.83229880 |
| 122 | Adrenal overactivity (HP:0002717) | 1.83171688 |
| 123 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 1.83007585 |
| 124 | Methylmalonic aciduria (HP:0012120) | 1.82860029 |
| 125 | Hyperthyroidism (HP:0000836) | 1.82737580 |
| 126 | Mitochondrial inheritance (HP:0001427) | 1.79320574 |
| 127 | Inability to walk (HP:0002540) | 1.79128984 |
| 128 | Hyperactive renin-angiotensin system (HP:0000841) | 1.77583081 |
| 129 | Diminished movement (HP:0002374) | 1.77126528 |
| 130 | Ankle clonus (HP:0011448) | 1.76337626 |
| 131 | Akinesia (HP:0002304) | 1.76089023 |
| 132 | Vaginal atresia (HP:0000148) | 1.76043544 |
| 133 | Progressive inability to walk (HP:0002505) | 1.76025386 |
| 134 | Ketosis (HP:0001946) | 1.75573526 |
| 135 | Impaired smooth pursuit (HP:0007772) | 1.74762224 |
| 136 | Oligodactyly (hands) (HP:0001180) | 1.74398498 |
| 137 | Abnormality of liposaccharide metabolism (HP:0010968) | 1.73244705 |
| 138 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 1.73244705 |
| 139 | Abnormality of glycolipid metabolism (HP:0010969) | 1.73244705 |
| 140 | Muscular hypotonia of the trunk (HP:0008936) | 1.73169755 |
| 141 | Hyperphosphatemia (HP:0002905) | 1.72931499 |
| 142 | Abnormality of the renal medulla (HP:0100957) | 1.71614628 |
| 143 | Abnormality of the corticospinal tract (HP:0002492) | 1.71158229 |
| 144 | Gait imbalance (HP:0002141) | 1.70435594 |
| 145 | Acute encephalopathy (HP:0006846) | 1.70062100 |
| 146 | Congenital stationary night blindness (HP:0007642) | 1.69852504 |
| 147 | Hypotension (HP:0002615) | 1.68585299 |
| 148 | Thoracolumbar scoliosis (HP:0002944) | 1.67683509 |
| 149 | Abnormality of the intrinsic pathway (HP:0010989) | 1.64997408 |
| 150 | Abnormal autonomic nervous system physiology (HP:0012332) | 1.64804838 |
| 151 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 1.62311601 |
| 152 | Febrile seizures (HP:0002373) | 1.61697761 |
| 153 | Chronic bronchitis (HP:0004469) | 1.61200462 |
| 154 | Limb dystonia (HP:0002451) | 1.59602539 |
| 155 | Anteriorly placed anus (HP:0001545) | 1.57521718 |
| 156 | Spinal canal stenosis (HP:0003416) | 1.57449009 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | INSRR | 5.37961134 |
| 2 | PRKD3 | 3.74071959 |
| 3 | MAPK15 | 3.55689643 |
| 4 | PASK | 3.54676845 |
| 5 | NTRK3 | 3.42115914 |
| 6 | MAP3K2 | 2.92122734 |
| 7 | TAOK3 | 2.62173122 |
| 8 | HIPK2 | 2.50550186 |
| 9 | NTRK1 | 2.41725225 |
| 10 | FRK | 2.34823200 |
| 11 | UHMK1 | 2.22458155 |
| 12 | WNK3 | 2.20705413 |
| 13 | FGFR2 | 2.09425720 |
| 14 | MAP4K2 | 2.03664181 |
| 15 | CAMKK2 | 1.91410062 |
| 16 | MAP3K9 | 1.84255271 |
| 17 | WNK4 | 1.77263663 |
| 18 | MARK1 | 1.72978456 |
| 19 | SCYL2 | 1.62677690 |
| 20 | MAP3K1 | 1.60548298 |
| 21 | MAP3K4 | 1.55752937 |
| 22 | CSNK1G1 | 1.49597336 |
| 23 | KSR2 | 1.46587397 |
| 24 | CDC42BPA | 1.45978387 |
| 25 | CSNK1G3 | 1.45369834 |
| 26 | EPHA4 | 1.43190811 |
| 27 | PLK2 | 1.35235670 |
| 28 | MINK1 | 1.34277128 |
| 29 | GRK1 | 1.32245968 |
| 30 | PRKCH | 1.30656557 |
| 31 | DYRK2 | 1.29141118 |
| 32 | NTRK2 | 1.28755439 |
| 33 | ADRBK2 | 1.25637542 |
| 34 | MAP2K7 | 1.25239679 |
| 35 | PAK3 | 1.18983779 |
| 36 | PAK6 | 1.14515089 |
| 37 | SGK223 | 1.11230925 |
| 38 | SGK494 | 1.11230925 |
| 39 | CAMKK1 | 1.10929136 |
| 40 | PDGFRA | 1.10781888 |
| 41 | CDK5 | 1.07868680 |
| 42 | RET | 1.06812003 |
| 43 | GRK5 | 1.05960031 |
| 44 | IRAK1 | 1.05945647 |
| 45 | MKNK2 | 1.02005329 |
| 46 | CSNK1A1L | 1.01655831 |
| 47 | CASK | 1.00745154 |
| 48 | EPHA3 | 1.00598212 |
| 49 | PHKG1 | 0.99747509 |
| 50 | PHKG2 | 0.99747509 |
| 51 | WNK1 | 0.97291762 |
| 52 | MAPK13 | 0.97205070 |
| 53 | SGK2 | 0.96169090 |
| 54 | STK38L | 0.92270963 |
| 55 | OXSR1 | 0.91409548 |
| 56 | AKT3 | 0.90810620 |
| 57 | PRKCE | 0.90056097 |
| 58 | DAPK2 | 0.87971253 |
| 59 | TRIM28 | 0.85563674 |
| 60 | STK16 | 0.84542266 |
| 61 | ERBB3 | 0.83634512 |
| 62 | PTK2 | 0.83555854 |
| 63 | FLT3 | 0.83090588 |
| 64 | PRKCG | 0.81992691 |
| 65 | PRKD2 | 0.80099168 |
| 66 | TNIK | 0.79892126 |
| 67 | ERN1 | 0.77622133 |
| 68 | ACVR1B | 0.77194988 |
| 69 | MAP2K6 | 0.76717697 |
| 70 | TSSK6 | 0.74101244 |
| 71 | CAMK2D | 0.73802268 |
| 72 | LMTK2 | 0.70814401 |
| 73 | CAMK1 | 0.70759590 |
| 74 | ARAF | 0.70431010 |
| 75 | FER | 0.69382374 |
| 76 | BRAF | 0.68873992 |
| 77 | MAP2K4 | 0.68291095 |
| 78 | STK11 | 0.68022190 |
| 79 | SGK3 | 0.67947119 |
| 80 | PIK3CG | 0.67597226 |
| 81 | IRAK2 | 0.67267100 |
| 82 | DYRK1A | 0.63974247 |
| 83 | CAMK2B | 0.62916153 |
| 84 | CAMK2A | 0.59888033 |
| 85 | MARK2 | 0.59160629 |
| 86 | PLK3 | 0.59083315 |
| 87 | PRKCZ | 0.57726325 |
| 88 | CDK3 | 0.57561699 |
| 89 | CAMK1D | 0.56498137 |
| 90 | IRAK3 | 0.55910081 |
| 91 | LIMK1 | 0.55844898 |
| 92 | CSNK1E | 0.55557037 |
| 93 | PRKAA1 | 0.54683713 |
| 94 | PNCK | 0.53966287 |
| 95 | CSNK1D | 0.52873094 |
| 96 | BRSK1 | 0.52397533 |
| 97 | RPS6KA2 | 0.52282633 |
| 98 | PINK1 | 0.51738734 |
| 99 | KSR1 | 0.51471324 |
| 100 | SIK2 | 0.51066292 |
| 101 | PRKG1 | 0.50824372 |
| 102 | PTK2B | 0.50193312 |
| 103 | PKN1 | 0.49351229 |
| 104 | TRIB3 | 0.49114635 |
| 105 | SGK1 | 0.49020116 |
| 106 | CAMK2G | 0.48465090 |
| 107 | BMPR2 | 0.47660195 |
| 108 | ADRBK1 | 0.45872037 |
| 109 | BMPR1B | 0.45821523 |
| 110 | PRPF4B | 0.45008547 |
| 111 | STK39 | 0.44551051 |
| 112 | PRKACG | 0.44480254 |
| 113 | MST4 | 0.44310944 |
| 114 | CSNK1G2 | 0.43996031 |
| 115 | PRKACA | 0.43622989 |
| 116 | ZAK | 0.43375026 |
| 117 | CSNK1A1 | 0.42755411 |
| 118 | MET | 0.42717367 |
| 119 | TNK2 | 0.42708053 |
| 120 | MAP2K1 | 0.42420675 |
| 121 | DYRK1B | 0.40774732 |
| 122 | RPS6KA3 | 0.40144436 |
| 123 | MAPK10 | 0.39893464 |
| 124 | PTK6 | 0.39009275 |
| 125 | NEK6 | 0.38120793 |
| 126 | RPS6KB1 | 0.37621585 |
| 127 | NLK | 0.36417342 |
| 128 | BCR | 0.36345767 |
| 129 | DAPK1 | 0.35796990 |
| 130 | CAMK1G | 0.35615073 |
| 131 | CDK14 | 0.35162193 |
| 132 | PRKCA | 0.34074469 |
| 133 | PRKDC | 0.33969346 |
| 134 | MAP3K12 | 0.32976512 |
| 135 | JAK2 | 0.32778350 |
| 136 | CAMK4 | 0.32547908 |
| 137 | PRKACB | 0.32337820 |
| 138 | SIK1 | 0.32140433 |
| 139 | PRKD1 | 0.31989028 |
| 140 | PDPK1 | 0.31141472 |
| 141 | RIPK4 | 0.30630872 |
| 142 | FGFR3 | 0.29994299 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 6.22884859 |
| 2 | Insulin secretion_Homo sapiens_hsa04911 | 3.54396773 |
| 3 | Protein export_Homo sapiens_hsa03060 | 3.41278593 |
| 4 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 2.20708607 |
| 5 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 2.20090022 |
| 6 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 2.17664879 |
| 7 | Sulfur metabolism_Homo sapiens_hsa00920 | 2.09340982 |
| 8 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 2.07959120 |
| 9 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 2.05265521 |
| 10 | Cocaine addiction_Homo sapiens_hsa05030 | 2.02186497 |
| 11 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 2.00807499 |
| 12 | GABAergic synapse_Homo sapiens_hsa04727 | 1.96774909 |
| 13 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.95190449 |
| 14 | Amphetamine addiction_Homo sapiens_hsa05031 | 1.94067274 |
| 15 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.92469112 |
| 16 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.88447931 |
| 17 | Taste transduction_Homo sapiens_hsa04742 | 1.83364434 |
| 18 | Circadian entrainment_Homo sapiens_hsa04713 | 1.80290335 |
| 19 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.79621515 |
| 20 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 1.77771909 |
| 21 | Long-term potentiation_Homo sapiens_hsa04720 | 1.70768087 |
| 22 | Dopaminergic synapse_Homo sapiens_hsa04728 | 1.66635046 |
| 23 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 1.62697959 |
| 24 | Morphine addiction_Homo sapiens_hsa05032 | 1.58446621 |
| 25 | Nicotine addiction_Homo sapiens_hsa05033 | 1.56519072 |
| 26 | Glutamatergic synapse_Homo sapiens_hsa04724 | 1.55848030 |
| 27 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.54738949 |
| 28 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.47304514 |
| 29 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.41007526 |
| 30 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.40870734 |
| 31 | Parkinsons disease_Homo sapiens_hsa05012 | 1.30084932 |
| 32 | Pancreatic secretion_Homo sapiens_hsa04972 | 1.29996290 |
| 33 | Circadian rhythm_Homo sapiens_hsa04710 | 1.29859036 |
| 34 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.28486450 |
| 35 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.23638774 |
| 36 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 1.20693784 |
| 37 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 1.20174661 |
| 38 | Olfactory transduction_Homo sapiens_hsa04740 | 1.19300275 |
| 39 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.11450853 |
| 40 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.11185232 |
| 41 | Salivary secretion_Homo sapiens_hsa04970 | 1.10359706 |
| 42 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.09992495 |
| 43 | Alzheimers disease_Homo sapiens_hsa05010 | 1.09265788 |
| 44 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.08855980 |
| 45 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.07684012 |
| 46 | Lysosome_Homo sapiens_hsa04142 | 1.07532254 |
| 47 | Renin secretion_Homo sapiens_hsa04924 | 1.06811059 |
| 48 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.06271914 |
| 49 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.05998602 |
| 50 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 1.03555870 |
| 51 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 1.01699821 |
| 52 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.00385214 |
| 53 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.99797079 |
| 54 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.99407718 |
| 55 | Long-term depression_Homo sapiens_hsa04730 | 0.98898006 |
| 56 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.95228152 |
| 57 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.93143148 |
| 58 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.92564468 |
| 59 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.91544388 |
| 60 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.90248513 |
| 61 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.89846943 |
| 62 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.89740804 |
| 63 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.89224171 |
| 64 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.88356640 |
| 65 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.86245944 |
| 66 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.85424142 |
| 67 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.83276615 |
| 68 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.83154663 |
| 69 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.78743476 |
| 70 | Prion diseases_Homo sapiens_hsa05020 | 0.78231067 |
| 71 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.77867028 |
| 72 | Gap junction_Homo sapiens_hsa04540 | 0.76385091 |
| 73 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.75290149 |
| 74 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.72272306 |
| 75 | Huntingtons disease_Homo sapiens_hsa05016 | 0.71079945 |
| 76 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.70055081 |
| 77 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.68347778 |
| 78 | Insulin resistance_Homo sapiens_hsa04931 | 0.66418706 |
| 79 | Melanogenesis_Homo sapiens_hsa04916 | 0.66085807 |
| 80 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.65349195 |
| 81 | Peroxisome_Homo sapiens_hsa04146 | 0.64524719 |
| 82 | Alcoholism_Homo sapiens_hsa05034 | 0.62197082 |
| 83 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.61247019 |
| 84 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.59348996 |
| 85 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.58690189 |
| 86 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.58567850 |
| 87 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.57711771 |
| 88 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.57516607 |
| 89 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.57392422 |
| 90 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.54701270 |
| 91 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.53177013 |
| 92 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.52663266 |
| 93 | Glioma_Homo sapiens_hsa05214 | 0.52030620 |
| 94 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.51012610 |
| 95 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.50722124 |
| 96 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.50224913 |
| 97 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.48985411 |
| 98 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.48983207 |
| 99 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.48657536 |
| 100 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.47852239 |
| 101 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.46955477 |
| 102 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.46055161 |
| 103 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.41797019 |
| 104 | Other glycan degradation_Homo sapiens_hsa00511 | 0.41586240 |
| 105 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.40967148 |
| 106 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.40797718 |
| 107 | ABC transporters_Homo sapiens_hsa02010 | 0.40435615 |
| 108 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.39411445 |
| 109 | Axon guidance_Homo sapiens_hsa04360 | 0.39210263 |
| 110 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.38390242 |
| 111 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.38240532 |
| 112 | Galactose metabolism_Homo sapiens_hsa00052 | 0.36570331 |
| 113 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.35713265 |
| 114 | Basal transcription factors_Homo sapiens_hsa03022 | 0.35478845 |
| 115 | RNA polymerase_Homo sapiens_hsa03020 | 0.34028311 |
| 116 | Metabolic pathways_Homo sapiens_hsa01100 | 0.33357849 |
| 117 | Endometrial cancer_Homo sapiens_hsa05213 | 0.32280199 |
| 118 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.31932674 |
| 119 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.31766171 |
| 120 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.31671456 |
| 121 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.30982895 |
| 122 | Bile secretion_Homo sapiens_hsa04976 | 0.30503701 |
| 123 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.30050478 |
| 124 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.29991969 |
| 125 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.28395667 |
| 126 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.27737054 |
| 127 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.27542157 |
| 128 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.27477644 |
| 129 | Endocytosis_Homo sapiens_hsa04144 | 0.27213025 |
| 130 | Phototransduction_Homo sapiens_hsa04744 | 0.26520339 |
| 131 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.26065276 |
| 132 | Mineral absorption_Homo sapiens_hsa04978 | 0.25320422 |

